Health technology assessment: a framework.
作者信息
Joore Manuela, Grimm Sabine, Boonen Annelies, de Wit Maarten, Guillemin Francis, Fautrel Bruno
机构信息
KEMTA, Maastricht University Medical Center, Maastricht, Netherlands.
KEMTA, Maastricht University Medical Center, Maastricht, Netherlands
出版信息
RMD Open. 2020 Nov;6(3). doi: 10.1136/rmdopen-2020-001289.
Abstract
摘要
相似文献
1
Health technology assessment: a framework.
RMD Open. 2020 Nov;6(3). doi: 10.1136/rmdopen-2020-001289.
2
The future impact of science and technology on medicine: basic research.
Vital Speeches Day. 1973 Nov 15;40(2):75-80.
3
Diffusion of high technology medical care and cost control--a public policy dilemma.
Technol Soc. 1981;3(3):305-22. doi: 10.1016/0160-791x(81)90002-6.
4
How do cardiologists face health economics and health technology assessments?
Eur Heart J. 2012 Nov;33(22):2757-8.
5
Updating the biomedical engineering curriculum: Inclusion of Health Technology Assessment subjects.
Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:2967-70. doi: 10.1109/IEMBS.2010.5626160.
6
Health technology assessment in Europe.
Scand J Public Health. 2009 Jun;37(4):335-9. doi: 10.1177/1403494809105860.
7
Medical technology "arms race" adds billions to the nation's bills: the price of health.
N Y Times Web. 1991 Apr 29:A1, B8.
8
Controlling health care costs by controlling technology: a private contractual approach.
Yale Law J. 1990 Mar;99(5):1109-26.
9
Transforming mortality: technology and the allocation of resources.
South Calif Law Rev. 1991 Nov;65(1):205-24.
10
The ethics and economics of high-technology medicine.
Contemp Ther. 1983 Dec;9(12):6-16.
引用本文的文献
1
Health technology assessment (HTA) and performance management (PM): a scoping review on the intersecting realms.
BMC Health Serv Res. 2025 Jul 3;25(1):917. doi: 10.1186/s12913-025-12879-3.
2
How can actuarial science contribute to the field of health technology assessment? An interdisciplinary perspective.
Int J Technol Assess Health Care. 2025 Jan 6;41(1):e3. doi: 10.1017/S0266462324004781.
3
Behind the scenes of EQA - characteristics, capabilities, benefits and assets of external quality assessment (EQA).
Clin Chem Lab Med. 2025 Jan 6;63(5):898-915. doi: 10.1515/cclm-2024-1293. Print 2025 Apr 28.
4
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.
5
A roadmap towards implementing health technology assessment in Oman.
J Health Organ Manag. 2024 Jul 12;38(9):241-257. doi: 10.1108/JHOM-01-2024-0012.
6
Developing and Evaluating Digital Public Health Interventions Using the Digital Public Health Framework DigiPHrame: A Framework Development Study.
J Med Internet Res. 2024 Sep 12;26:e54269. doi: 10.2196/54269.
7
Cost-effectiveness analysis of proximal femoral nail versus bipolar hemiarthroplasty for femoral neck fracture.
J Orthop Surg Res. 2024 Aug 27;19(1):507. doi: 10.1186/s13018-024-04941-3.
8
Overcoming Barriers in Hospital-Based Health Technology Assessment (HB-HTA): International Expert Panel Consensus.
Healthcare (Basel). 2024 Apr 25;12(9):889. doi: 10.3390/healthcare12090889.
9
A health technology assessment of personalized nutrition interventions using the EUnetHTA HTA Core Model.
Int J Technol Assess Health Care. 2024 Mar 6;40(1):e15. doi: 10.1017/S0266462324000060.
10
Economic Evaluation of a Personalized Nutrition Plan Based on Omic Sciences Versus a General Nutrition Plan in Adults with Overweight and Obesity: A Modeling Study Based on Trial Data in Denmark.
Pharmacoecon Open. 2024 Mar;8(2):313-331. doi: 10.1007/s41669-023-00461-8. Epub 2023 Dec 19.
本文引用的文献
1
Health Technology Assessment: Global Advocacy and Local Realities Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness".
Int J Health Policy Manag. 2017 Apr 1;6(4):233-236. doi: 10.15171/ijhpm.2016.118.
2
Clinical trials provide essential evidence, but rarely offer a vehicle for cost-effectiveness analysis.
Value Health. 2015 Mar;18(2):141-2. doi: 10.1016/j.jval.2015.02.005.
3
Mapping of health technology assessment in selected countries.
Int J Technol Assess Health Care. 2013 Oct;29(4):424-34. doi: 10.1017/S0266462313000469.
4
Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.
Value Health. 2005 Sep-Oct;8(5):521-33. doi: 10.1111/j.1524-4733.2005.00045.x.
Zotero 插件